Mirae Asset Global ETFs Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.7M	Buy	82,100 +18,149	+28%	+$994K	0.01%	884
2026 Q1	$3.6M	Buy	63,951 +1,918	+3%	+$112K	﹤0.01%	933
2025 Q4	$3.68M	Buy	62,033 +21,624	+54%	+$1.18M	0.01%	911
2025 Q3	$2.19M	Sell	40,409 -2,126	-5%	-$122K	﹤0.01%	1104
2025 Q2	$2.34M	Sell	42,535 -9,954	-19%	-$586K	﹤0.01%	1022
2025 Q1	$3.72M	Sell	52,489 -5,118	-9%	-$344K	0.01%	857
2024 Q4	$3.78M	Buy	57,607 +13,560	+31%	+$908K	0.01%	854
2024 Q3	$3.1M	Sell	44,047 -8,301	-16%	-$694K	0.01%	929
2024 Q2	$4.32M	Buy	+52,348	New	+$4.36M	0.01%	793

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BMRN Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its BioMarin Pharmaceuticals (BMRN) stake by 28% in Q2 2026, buying an estimated $994K and bringing the position to 82,100 shares worth $4.7M. The position accounts for 0.01% of the portfolio, ranked #884.

Mirae Asset Global ETFs Holdings first reported a position in BMRN in Q2 2024 and has held it in 9 quarters since. 561 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Mirae Asset Global ETFs Holdings held 82,100 shares of BioMarin Pharmaceuticals worth $4.7M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 18,149 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $994K.
BioMarin Pharmaceuticals made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #884 holding.
Mirae Asset Global ETFs Holdings first reported a position in BioMarin Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.